Regulation of class I major histocompatibility complex receptor expression in natural killer cells: One promoter is not enough!

Immunological Reviews

Volumn 214, Issue 1, 2006, Pages 9-21

  Pascal, Véronique ^a   Stulberg, Michael J ^a   Anderson, Stephen K ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Human; KIR; Ly49; Natural killer cells; Rodent; Transcription factors

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

DNA PROBE; GENE; GENE ACTIVATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; IMMUNOREGULATION; KIR GENE; METHYLATION; MULTIGENE FAMILY; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIGENS, LY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC;

EID: 33750707891     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00452.x     Document Type: Review

References (98)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
2. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41-49.
3. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-274.
4. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001;181:158-169.
5. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002;14:615-621.
6. Anderson SK, Ortaldo JR, McVicar DW. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev 2001;181:79-89.
7. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
8. Carrington M, Norman P. The KIR Gene Cluster. Bethesda, MD: National Library of Medicine (US), NCBI, 2001.
9. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5:201-214.
10. Vidal SM, Lanier LL. NK cell recognition of mouse cytomegalovirus- infected cells. Curr Top Microbiol Immunol 2006;298:183-206.
11. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993;11:613-635.
12. Brown MG, et al. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 1997;42:16-25.
13. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997;155:53-65.
14. McQueen KL, Freeman JD, Takei F, Mager DL. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 1998;48:174-183.
15. Depatie C, et al. Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus Cmv1. Genomics 2000;66:161-174.
16. Wilhelm BT, Gagnier L, Mager DL. Sequence analysis of the ly49 cluster in C57BL/6 mice: a rapidly evolving multigene family in the immune system. Genomics 2002;80:646-661.
17. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 2002;79:437-444.
18. Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun 2005;6:71-83.
19. Proteau MF, Rousselle E, Makrigiannis AP. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 2004;84:669-677.
20. Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun 2005;6:481-492.
21. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992;358:66-70.
22. Brennan J, Mager D, Jefferies W, Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 1994;180:2287-2295.
23. Stoneman ER, et al. Cloning and characterization of 5E6 (Ly49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med 1995;182:305-313.
24. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med 1995;182:293-303.
25. Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 1995;376:355-358.
26. Held W, Raulet DH. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively monoallelic. Eur J Immunol 1997;27:2876-2884.
27. Kubota A, Kubota S, Lohwasser S, Mager DL, Takei F. Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol 1999;163:212-216.
28. Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med 1997;185:2079-2088.
29. Held W, Kunz B. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol 1998;28:2407-2416.
30. Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, Yokoyama WM. Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med 2000;191:1341-1354.
31. Toomey JA, et al. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 1998;28:47-56.
32. Van Beneden K, et al. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 2001;166:4302-4311.
33. Fraser KP, et al. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 2002;32:868-878.
34. Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 1998;187:609-618.
35. Stevenaert F, Van Beneden K, De Creus A, Debacker V, Plum J, Leclercq G. Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors. J Leukoc Biol 2003;73:731-738.
36. Roth C, Carlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 2000;13:143-153.
37. Williams NS, Kubota A, Bennett M, Kumar V, Takei F. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Eur J Immunol 2000;30:2074-2082.
38. Kubo S, Itoh Y, Ishikawa N, Nagasawa R, Mitarai T, Maruyama N. The gene encoding mouse lymphocyte antigen Ly-49: structural analysis and the 5′-flanking sequence. Gene 1993;136:329-331.
39. Gosselin P, Makrigiannis AP, Nalewaik R, Anderson SK. Characterization of the Ly49I promoter. Immunogenetics 2000;51:326-331.
40. McQueen KL, Wilhelm BT, Takei F, Mager DL. Functional analysis of 5′ and 3′ regions of the closely related Ly49c and j genes. Immunogenetics 2001;52:212-223.
41. Kunz B, Held W. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells. J Immunol 2001;166:6181-6187.
42. Kubo S, Nagasawa R, Nishimura H, Shigemoto K, Maruyama N. ATF-2-binding regulatory element is responsible for the Ly49A expression in murine T lymphoid line, EL-4. Biochim Biophys Acta 1999;1444:191-200.
43. Held W, Kunz B, Lowin-Kropf B, van de Wetering M, Clevers H. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 1999;11:433-442.
44. Ioannidis V, Kunz B, Tanamachi DM, Scarpellino L, Held W. Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1. J Immunol 2003;171:769-775.
45. Held W, Clevers H, Grosschedl R. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol 2003;33:1393-1398.
46. Schilham MW, Wilson A, Moerer P, Benaissa-Trouw BJ, Cumano A, Clevers HC. Critical involvement of Tcf-1 in expansion of thymocytes. J Immunol 1998;161:3984-3991.
47. Saleh A, Makrigiannis AP, Hodge DL, Anderson SK. Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J Immunol 2002;168:5163-5169.
48. Wilhelm BT, McQueen KL, Freeman JD, Takei F, Mager DL. Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes. Immunogenetics 2001;53:215-224.
49. Tsutsui H, et al. IFN-g-inducing factor upregulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-3973.
50. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004;172:1074-1082.
51. Lian RH, Chin RK, Nemeth HE, Libby SL, Fu YX, Kumar V. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Eur J Immunol 2004;34:2699-2707.
52. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003;3:413-425.
53. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004;22:405-429.
54. Taki S, Nakajima S, Ichikawa E, Saito T, Hida S. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J Immunol 2005;174:6005-6012.
55. Gays F, Martin K, Kenefeck R, Aust JG, Brooks CG. Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. J Immunol 2005;175:2938-2947.
56. Vosshenrich CA, Samson-Villeger SI, Di Santo JP. Distinguishing features of developing natural killer cells. Curr Opin Immunol 2005;17:151-158.
57. Vosshenrich CA, et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005;174:1213-1221.
58. Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol 2005;175:749-754.
59. Kim S, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002;3:523-528.
60. Saleh A, et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004;21:55-66.
61. Kaisho T, et al. Impairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient mice. J Exp Med 1999;190:1573-1582.
62. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005;105:4416-4423.
63. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436:709-713.
64. Samson, SI, et al. Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation. Blood 2004;103:4573-4580.
65. Rouhi A, Gagnier L, Takei F, Mager DL. Evidence for epigenetic maintenance of Ly49a monoallelic gene expression. J Immunol 2006;176:2991-2999.
66. Foley KP, Engel JD. Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin gene switching. Genes Dev 1992;6:730-744.
67. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic context of natural killer receptor extended gene families. Immunol Rev 2001;181:20-38.
68. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002;190:40-52.
69. Uhrberg M, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-763.
70. Wilson MJ, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000;97:4778-4783.
71. Moretta A, et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990;172:1589-1598.
72. Ciccone E, et al. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med 1992;175:709-718.
73. Wagtmann N, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
74. Valiante NM, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739-751.
75. Husain Z, Alper CA, Yunis EJ, Dubey DP. Complex expression of natural killer receptor genes in single natural killer cells. Immunology 2002;106:373-380.
76. Santourlidis S, et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002;169:4253-4261.
77. Chan HW, et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med 2003;197:245-255.
78. Chan HW, Miller JS, Moore MB, Lutz CT. Epigenetic control of highly homologous killer immunoglobulin-like receptor gene alleles. J Immunol 2005;175:5966-5974.
79. Van Bergen J, Stewart CA, van den Elsen PJ, Trowsdale J. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur J Immunol 2005;35:2191-2199.
80. Stewart CA, Van Bergen J, Trowsdale J. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J Immunol 2003;170:6073-6081.
81. Trompeter HI, et al. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol 2005;174:4335-4343.
82. Presnell SR, Zhang L, Ramilo CA, Chan HW, Lutz CT. Functional Redundancy of transcription factor binding sites in the killer cell immunoglobulin-like receptor (KIR) gene promoter. Int Immunol 2006;18:1221-1232.
83. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000;165:6416-6421.
84. Xu J, Vallejo AN, Jiang Y, Weyand CM, Goronzy JJ. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem 2005;280:24277-24285.
85. Radeloff B, Nagler L, Zirra M, Ziegler A, Volz A. Specific amplification of cDNA ends (SPACE): a new tool for the analysis of rare transcripts and its application for the promoter analysis of killer cell receptor genes. DNA Seq 2005;16:44-52.
86. Fukagawa T, et al. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol 2004;6:784-791.
87. Kanellopoulou C, et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 2005;19:489-501.
88. Haussecker D, Proudfoot NJ. Dicer-dependent turnover of intergenic transcripts from the human beta-globin gene cluster. Mol Cell Biol 2005;25:9724-9733.
89. Kawasaki H, Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 2004;431:211-217.
90. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004;305:1289-1292.
91. Chakalova L, et al. The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression. Blood 2005;105:2154-2160.
92. Loots GG, et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000;288:136-140.
93. Jones EA, Flavell RA. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J Immunol 2005;175:7437-7446.
94. Guo L, Hu-Li J, Paul WE. Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity 2005;23:89-99.
95. Guo L, Hu-Li J, Paul WE. Probabilistic regulation of IL-4 production in Th2 cells: accessibility at the Il4 locus. Immunity 2004;20:193-203.
96. Rogan DF, Cousins DJ, Staynov DZ. Intergenic transcription occurs throughout the human IL-4/IL-13 gene cluster. Biochem Biophys Res Commun 1999;255:556-561.
97. Rogan DF, et al. Analysis of intergenic transcription in the human IL-4/IL-13 gene cluster. Proc Natl Acad Sci USA 2004;101:2446-2451.
98. Baguet A, Sun X, Arroll T, Krumm A, Bix M. Intergenic transcription is not required in Th2 cells to maintain histone acetylation and transcriptional permissiveness at the Il4-Il13 locus. J Immunol 2005;175:8146-8153.